Verastem, Inc. Research and Development Expense
Verastem, Inc. (VSTM) reported Research and Development Expense of $41.34 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-06
- Verastem, Inc. research and development expense for the quarter ending 2026-06-30 was $41.34M, a 66.78% increase year-over-year.
- Verastem, Inc. research and development expense for the quarter ending 2026-03-31 was $38.22M, a 31.10% increase year-over-year.
- Verastem, Inc. research and development expense for the quarter ending 2025-12-31 was $31.67M, a 52.20% increase year-over-year.
- Verastem, Inc. research and development expense for the quarter ending 2025-09-30 was $28.99M, a 17.11% increase year-over-year.
- Verastem, Inc. research and development expense for fiscal 2025 was $114.60M, a 40.90% increase from fiscal 2024.
- Verastem, Inc. research and development expense for fiscal 2024 was $81.33M, a 32.56% increase from fiscal 2023.
- Verastem, Inc. research and development expense for fiscal 2023 was $61.36M, a 21.36% increase from fiscal 2022.
- Verastem, Inc. research and development expense for fiscal 2022 was $50.56M, a 28.49% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 5 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month | Research and Development Expense 20 month | Research and Development Expense 23 month | Research and Development Expense 26 month | Research and Development Expense 29 month | Research and Development Expense 32 month | Research and Development Expense 35 month | Research and Development Expense 38 month | Research and Development Expense 41 month | Research and Development Expense 44 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $41.34M 10-Q · filed 2026-08-06 | $79.56M 10-Q · filed 2026-08-06 | $111.23M derived: sum of 3 quarters · filed 2026-08-06 | $140.22M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||
| 2026-03-31 | $38.22M 10-Q · filed 2026-05-07 | $69.89M derived: sum of 2 quarters · filed 2026-05-07 | $98.88M derived: sum of 3 quarters · filed 2026-05-07 | $123.67M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||
| 2025-12-31 | $31.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $60.66M derived: sum of 2 quarters · filed 2026-03-04 | $85.45M derived: sum of 3 quarters · filed 2026-08-06 | $114.60M 10-K · filed 2026-03-04 | ||||||||||
| 2025-09-30 | $28.99M 10-Q · filed 2025-11-04 | $53.77M derived: sum of 2 quarters · filed 2026-08-06 | $82.92M 10-Q · filed 2025-11-04 | $103.74M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||
| 2025-06-30 | $24.79M 10-Q · filed 2026-08-06 | $53.94M 10-Q · filed 2026-08-06 | $74.75M derived: sum of 3 quarters · filed 2026-08-06 | $99.50M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||
| 2025-03-31 | $29.15M 10-Q · filed 2026-05-07 | $49.96M derived: sum of 2 quarters · filed 2026-05-07 | $74.72M derived: sum of 3 quarters · filed 2026-05-07 | $92.78M derived: sum of 4 quarters · filed 2026-05-07 | ||||||||||
| 2024-12-31 | $20.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $45.56M derived: sum of 2 quarters · filed 2026-03-04 | $63.63M derived: sum of 3 quarters · filed 2026-03-04 | $81.33M 10-K · filed 2026-03-04 | ||||||||||
| 2024-09-30 | $24.75M 10-Q · filed 2025-11-04 | $42.82M derived: sum of 2 quarters · filed 2025-11-04 | $60.52M 10-Q · filed 2025-11-04 | $83.03M derived: sum of 4 quarters · filed 2026-03-04 | ||||||||||
| 2024-06-30 | $18.06M 10-Q · filed 2025-08-07 | $35.77M 10-Q · filed 2025-08-07 | $58.27M derived: sum of 3 quarters · filed 2026-03-04 | $72.22M derived: sum of 4 quarters · filed 2026-03-04 | ||||||||||
| 2024-03-31 | $17.71M 10-Q · filed 2025-05-13 | $40.21M derived: sum of 2 quarters · filed 2026-03-04 | $54.16M derived: sum of 3 quarters · filed 2026-03-04 | $67.05M derived: sum of 4 quarters · filed 2026-03-04 | ||||||||||
| 2023-12-31 | $22.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $36.45M derived: sum of 2 quarters · filed 2026-03-04 | $49.34M derived: sum of 3 quarters · filed 2026-03-04 | $61.36M 10-K · filed 2026-03-04 | ||||||||||
| 2023-09-30 | $13.95M 10-Q · filed 2024-11-06 | $26.84M derived: sum of 2 quarters · filed 2024-11-06 | $38.85M 10-Q · filed 2024-11-06 | $49.59M derived: sum of 4 quarters · filed 2025-03-20 | ||||||||||
| 2023-06-30 | $12.89M 10-Q · filed 2024-08-08 | $24.91M 10-Q · filed 2024-08-08 | $35.65M derived: sum of 3 quarters · filed 2025-03-20 | $46.94M derived: sum of 4 quarters · filed 2025-03-20 | ||||||||||
| 2023-03-31 | $12.02M 10-Q · filed 2024-05-09 | $22.75M derived: sum of 2 quarters · filed 2025-03-20 | $34.04M derived: sum of 3 quarters · filed 2025-03-20 | $48.93M derived: sum of 4 quarters · filed 2025-03-20 | ||||||||||
| 2022-12-31 | $10.74M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $22.03M derived: sum of 2 quarters · filed 2025-03-20 | $36.92M derived: sum of 3 quarters · filed 2025-03-20 | $50.56M 10-K · filed 2025-03-20 | ||||||||||
| 2022-09-30 | $11.29M 10-Q · filed 2023-11-08 | $26.18M derived: sum of 2 quarters · filed 2023-11-08 | $39.82M 10-Q · filed 2023-11-08 | $51.21M derived: sum of 4 quarters · filed 2024-03-14 | ||||||||||
| 2022-06-30 | $14.89M 10-Q · filed 2023-08-08 | $28.53M 10-Q · filed 2023-08-08 | $39.93M derived: sum of 3 quarters · filed 2024-03-14 | $49.25M derived: sum of 4 quarters · filed 2024-03-14 | ||||||||||
| 2022-03-31 | $13.64M 10-Q · filed 2023-05-09 | $25.04M derived: sum of 2 quarters · filed 2024-03-14 | $34.36M derived: sum of 3 quarters · filed 2024-03-14 | $44.09M derived: sum of 4 quarters · filed 2024-03-14 | ||||||||||
| 2021-12-31 | $11.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $20.72M derived: sum of 2 quarters · filed 2024-03-14 | $30.45M derived: sum of 3 quarters · filed 2024-03-14 | $39.35M 10-K · filed 2024-03-14 | ||||||||||
| 2021-09-30 | $9.32M 10-Q · filed 2022-11-03 | $19.05M derived: sum of 2 quarters · filed 2022-11-03 | $27.95M 10-Q · filed 2022-11-03 | $38.10M derived: sum of 4 quarters · filed 2022-11-03 | ||||||||||
| 2021-06-30 | $9.73M 10-Q · filed 2022-08-08 | $18.63M 10-Q · filed 2022-08-08 | $28.78M derived: sum of 3 quarters · filed 2022-08-08 | $39.73M derived: sum of 4 quarters · filed 2022-08-08 | ||||||||||
| 2021-03-31 | $8.90M 10-Q · filed 2022-05-09 | $19.05M derived: sum of 2 quarters · filed 2022-05-09 | $30.00M derived: sum of 3 quarters · filed 2022-05-09 | $39.35M derived: sum of 4 quarters · filed 2022-05-09 | ||||||||||
| 2020-12-31 | $10.15M 10-K · filed 2021-03-18 | $21.11M derived: sum of 2 quarters · filed 2021-11-04 | $30.45M derived: sum of 3 quarters · filed 2021-11-04 | $41.38M 10-K · filed 2023-03-14 | ||||||||||
| 2020-09-30 | $10.96M 10-Q · filed 2021-11-04 | $20.30M derived: sum of 2 quarters · filed 2021-11-04 | $31.22M 10-Q · filed 2021-11-04 | $43.68M derived: sum of 4 quarters · filed 2021-11-04 | ||||||||||
| 2020-06-30 | $9.34M 10-Q · filed 2021-08-02 | $20.27M 10-Q · filed 2021-08-02 | $32.72M derived: sum of 3 quarters · filed 2021-08-02 | $44.94M derived: sum of 4 quarters · filed 2021-08-02 | ||||||||||
| 2020-03-31 | $10.92M 10-Q · filed 2021-05-11 | $23.38M derived: sum of 2 quarters · filed 2021-05-11 | $35.60M derived: sum of 3 quarters · filed 2021-05-11 | $46.94M derived: sum of 4 quarters · filed 2021-05-11 | ||||||||||
| 2019-12-31 | $12.46M 10-K · filed 2021-03-18 | $24.67M derived: sum of 2 quarters · filed 2021-03-18 | $36.02M derived: sum of 3 quarters · filed 2021-03-18 | $45.78M 10-K · filed 2022-03-28 | ||||||||||
| 2019-09-30 | $12.22M 10-K · filed 2021-03-18 | $23.57M derived: sum of 2 quarters · filed 2021-03-18 | $33.32M 10-Q · filed 2020-11-09 | $42.09M derived: sum of 4 quarters · filed 2021-03-18 | ||||||||||
| 2019-06-30 | $11.35M 10-K · filed 2021-03-18 | $21.10M 10-Q · filed 2020-08-10 | $29.87M derived: sum of 3 quarters · filed 2021-03-18 | $41.44M derived: sum of 4 quarters · filed 2021-03-18 | ||||||||||
| 2019-03-31 | $9.76M 10-K · filed 2021-03-18 | $18.52M derived: sum of 2 quarters · filed 2021-03-18 | $30.09M derived: sum of 3 quarters · filed 2021-03-18 | $42.47M derived: sum of 4 quarters · filed 2021-03-18 | ||||||||||
| 2018-12-31 | $8.76M 10-K · filed 2020-03-11 | $20.33M derived: sum of 2 quarters · filed 2020-03-11 | $32.71M derived: sum of 3 quarters · filed 2020-03-11 | $43.65M 10-K · filed 2021-03-18 | ||||||||||
| 2018-09-30 | $11.57M 10-K · filed 2020-03-11 | $23.95M derived: sum of 2 quarters · filed 2020-03-11 | $34.89M 10-Q · filed 2019-10-30 | $46.14M derived: sum of 4 quarters · filed 2020-03-11 | ||||||||||
| 2018-06-30 | $12.38M 10-K · filed 2020-03-11 | $23.32M 10-Q · filed 2019-08-01 | $34.57M derived: sum of 3 quarters · filed 2020-03-11 | $52.31M derived: sum of 4 quarters · filed 2020-03-11 | ||||||||||
| 2018-03-31 | $10.93M 10-K · filed 2020-03-11 | $22.19M derived: sum of 2 quarters · filed 2020-03-11 | $39.93M derived: sum of 3 quarters · filed 2020-03-11 | $48.97M derived: sum of 4 quarters · filed 2020-03-11 | ||||||||||
| 2017-12-31 | $11.25M 10-K · filed 2019-03-12 | $29.00M derived: sum of 2 quarters · filed 2019-03-12 | $38.04M derived: sum of 3 quarters · filed 2019-03-12 | $46.42M 10-K · filed 2020-03-11 | ||||||||||
| 2017-09-30 | $17.74M 10-K · filed 2019-03-12 | $26.79M derived: sum of 2 quarters · filed 2019-03-12 | $35.17M 10-Q · filed 2018-11-07 | $42.06M derived: sum of 4 quarters · filed 2019-03-12 | ||||||||||
| 2017-06-30 | $9.04M 10-K · filed 2019-03-12 | $17.43M 10-Q · filed 2018-08-08 | $24.32M derived: sum of 3 quarters · filed 2019-03-12 | $28.54M derived: sum of 4 quarters · filed 2019-03-12 | ||||||||||
| 2017-03-31 | $8.38M 10-K · filed 2019-03-12 | $15.28M derived: sum of 2 quarters · filed 2019-03-12 | $19.49M derived: sum of 3 quarters · filed 2019-03-12 | $23.98M derived: sum of 4 quarters · filed 2019-03-12 | ||||||||||
| 2016-12-31 | $6.89M 10-K · filed 2018-03-13 | $11.11M derived: sum of 2 quarters · filed 2018-03-13 | $15.60M derived: sum of 3 quarters · filed 2018-03-13 | $19.78M 10-K · filed 2019-03-12 | ||||||||||
| 2016-09-30 | $4.22M 10-K · filed 2018-03-13 | $8.71M derived: sum of 2 quarters · filed 2018-03-13 | $12.89M 10-Q · filed 2017-11-07 | $20.57M derived: sum of 4 quarters · filed 2018-03-13 | ||||||||||
| 2016-06-30 | $4.49M 10-K · filed 2018-03-13 | $8.67M 10-Q · filed 2017-08-08 | $16.36M derived: sum of 3 quarters · filed 2018-03-13 | $27.66M derived: sum of 4 quarters · filed 2018-03-13 | ||||||||||
| 2016-03-31 | $4.18M 10-K · filed 2018-03-13 | $11.87M derived: sum of 2 quarters · filed 2018-03-13 | $23.17M derived: sum of 3 quarters · filed 2018-03-13 | $34.22M derived: sum of 4 quarters · filed 2018-03-13 | ||||||||||
| 2015-12-31 | $7.69M 10-K · filed 2017-03-23 | $18.99M derived: sum of 2 quarters · filed 2017-03-23 | $30.04M derived: sum of 3 quarters · filed 2017-03-23 | $40.56M 10-K · filed 2018-03-13 | ||||||||||
| 2015-09-30 | $11.30M 10-K · filed 2017-03-23 | $22.35M derived: sum of 2 quarters · filed 2017-03-23 | $32.88M 10-Q · filed 2016-11-07 | $42.56M derived: sum of 4 quarters · filed 2017-03-23 | ||||||||||
| 2015-06-30 | $11.04M 10-K · filed 2017-03-23 | $21.57M 10-Q · filed 2016-08-08 | $31.26M derived: sum of 3 quarters · filed 2017-03-23 | $40.30M derived: sum of 4 quarters · filed 2017-03-23 | ||||||||||
| 2015-03-31 | $10.53M 10-K · filed 2017-03-23 | $20.21M derived: sum of 2 quarters · filed 2017-03-23 | $29.26M derived: sum of 3 quarters · filed 2017-03-23 | $37.56M derived: sum of 4 quarters · filed 2017-03-23 | ||||||||||
| 2014-12-31 | $9.69M 10-K · filed 2016-03-03 | $18.73M derived: sum of 2 quarters · filed 2016-03-03 | $27.04M derived: sum of 3 quarters · filed 2016-03-03 | $35.45M 10-K · filed 2017-03-23 | ||||||||||
| 2014-09-30 | $9.05M 10-K · filed 2016-03-03 | $17.35M derived: sum of 2 quarters · filed 2016-03-03 | $25.76M 10-Q · filed 2015-11-09 | $33.56M derived: sum of 4 quarters · filed 2016-03-03 | ||||||||||
| 2014-06-30 | $8.30M 10-K · filed 2016-03-03 | $16.72M 10-Q · filed 2015-08-10 | $24.52M derived: sum of 3 quarters · filed 2016-03-03 | $31.30M derived: sum of 4 quarters · filed 2016-03-03 | ||||||||||
| 2014-03-31 | $8.41M 10-K · filed 2016-03-03 | $16.21M derived: sum of 2 quarters · filed 2016-03-03 | $23.00M derived: sum of 3 quarters · filed 2016-03-03 | $29.05M derived: sum of 4 quarters · filed 2016-03-03 | $66.34M 10-Q · filed 2014-05-08 | |||||||||
| 2013-12-31 | $7.80M 10-K · filed 2015-03-10 | $14.59M derived: sum of 2 quarters · filed 2015-03-10 | $20.63M derived: sum of 3 quarters · filed 2015-03-10 | $25.93M 10-K · filed 2016-03-03 | $57.92M 10-K · filed 2014-03-06 | |||||||||
| 2013-09-30 | $6.79M 10-K · filed 2015-03-10 | $12.83M derived: sum of 2 quarters · filed 2015-03-10 | $18.13M 10-Q · filed 2014-10-30 | $22.22M derived: sum of 4 quarters · filed 2015-03-10 | $50.13M 10-Q · filed 2013-11-12 | |||||||||
| 2013-06-30 | $6.04M 10-K · filed 2015-03-10 | $11.34M 10-Q · filed 2014-08-07 | $15.44M derived: sum of 3 quarters · filed 2015-03-10 | $23.57M derived: sum of 4 quarters · filed 2015-03-10 | $43.34M 10-Q · filed 2013-08-13 | |||||||||
| 2013-03-31 | $5.30M 10-K · filed 2015-03-10 | $9.39M derived: sum of 2 quarters · filed 2015-03-10 | $17.52M derived: sum of 3 quarters · filed 2015-03-10 | $22.20M derived: sum of 4 quarters · filed 2015-03-10 | $37.29M 10-Q · filed 2013-05-09 | |||||||||
| 2012-12-31 | $4.09M 10-K · filed 2014-03-06 | $12.23M derived: sum of 2 quarters · filed 2014-03-06 | $16.91M derived: sum of 3 quarters · filed 2014-03-06 | $21.71M 10-K · filed 2015-03-10 | $32.00M 10-K · filed 2013-03-26 | |||||||||
| 2012-09-30 | $8.13M 10-K · filed 2014-03-06 | $12.81M derived: sum of 2 quarters · filed 2014-03-06 | $17.62M 10-Q · filed 2013-11-12 | $22.02M derived: sum of 4 quarters · filed 2014-03-06 | $27.90M 10-Q · filed 2012-11-13 | |||||||||
| 2012-06-30 | $4.68M 10-K · filed 2014-03-06 | $9.49M 10-Q · filed 2013-08-13 | $13.89M derived: sum of 3 quarters · filed 2014-03-06 | $16.97M derived: sum of 4 quarters · filed 2014-03-06 | $19.77M 10-Q · filed 2012-08-13 | |||||||||
| 2012-03-31 | $4.80M 10-K · filed 2014-03-06 | $9.20M derived: sum of 2 quarters · filed 2014-03-06 | $12.29M derived: sum of 3 quarters · filed 2014-03-06 | $14.01M derived: sum of 4 quarters · filed 2014-03-06 | $15.09M 10-Q · filed 2012-05-14 | |||||||||
| 2011-12-31 | $4.40M 10-K · filed 2013-03-26 | $7.48M derived: sum of 2 quarters · filed 2013-03-26 | $9.21M derived: sum of 3 quarters · filed 2013-03-26 | $9.88M 10-K · filed 2014-03-06 | ||||||||||
| 2011-09-30 | $3.08M 10-K · filed 2013-03-26 | $4.81M derived: sum of 2 quarters · filed 2013-03-26 | $5.48M 10-Q · filed 2012-11-13 | |||||||||||
| 2011-06-30 | $1.73M 10-K · filed 2013-03-26 | $2.40M 10-Q · filed 2012-08-13 | ||||||||||||
| 2011-03-31 | $675.00K 10-K · filed 2013-03-26 | |||||||||||||
| 2010-12-31 | $400.00K 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |